Kantoff PW - Search Results

1

Abiraterone Acetate Induces CREB1 Phosphorylation and Enhances the Function of the CBP-p300 Complex, Leading to Resistance in Prostate Cancer Cells.

Pan W, Zhang Z, Kimball H, Qu F, Berlind K, Stopsack KH, Lee GM, Choueiri TK, Kantoff PW. Pan W, et al. Among authors: kantoff pw. Clin Cancer Res. 2021 Apr 1;27(7):2087-2099. doi: 10.1158/1078-0432.CCR-20-4391. Epub 2021 Jan 25. Clin Cancer Res. 2021. PMID: 33495313 Free PMC article.

2

Two differentially expressed genes in normal human prostate tissue and in carcinoma.

Wang FL, Wang Y, Wong WK, Liu Y, Addivinola FJ, Liang P, Chen LB, Kantoff PW, Pardee AB. Wang FL, et al. Among authors: kantoff pw. Cancer Res. 1996 Aug 15;56(16):3634-7. Cancer Res. 1996. PMID: 8705997

3

Treatment of locally advanced prostate cancer: is chemotherapy the next step?

Oh WK, Kantoff PW. Oh WK, et al. Among authors: kantoff pw. J Clin Oncol. 1999 Nov;17(11):3664-75. doi: 10.1200/JCO.1999.17.11.3664. J Clin Oncol. 1999. PMID: 10550165 Review.

4

A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer.

Eder JP, Kantoff PW, Roper K, Xu GX, Bubley GJ, Boyden J, Gritz L, Mazzara G, Oh WK, Arlen P, Tsang KY, Panicali D, Schlom J, Kufe DW. Eder JP, et al. Among authors: kantoff pw. Clin Cancer Res. 2000 May;6(5):1632-8. Clin Cancer Res. 2000. PMID: 10815880 Clinical Trial.

5

Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.

George DJ, Halabi S, Shepard TF, Vogelzang NJ, Hayes DF, Small EJ, Kantoff PW; Cancer and Leukemia Group B 9480. George DJ, et al. Among authors: kantoff pw. Clin Cancer Res. 2001 Jul;7(7):1932-6. Clin Cancer Res. 2001. PMID: 11448906

6

Rapid rise of serum prostate specific antigen levels after discontinuation of the herbal therapy PC-SPES in patients with advanced prostate carcinoma: report of four cases.

Oh WK, George DJ, Kantoff PW. Oh WK, et al. Among authors: kantoff pw. Cancer. 2002 Feb 1;94(3):686-9. doi: 10.1002/cncr.10269. Cancer. 2002. PMID: 11857300 Free article.

7

Chemotherapy for prostate cancer.

Gilligan T, Kantoff PW. Gilligan T, et al. Among authors: kantoff pw. Urology. 2002 Sep;60(3 Suppl 1):94-100; discussion 100. doi: 10.1016/s0090-4295(02)01583-2. Urology. 2002. PMID: 12231060 Review.

8

A phase I study of estramustine, weekly docetaxel, and carboplatin chemotherapy in patients with hormone-refractory prostate cancer.

Oh WK, Hagmann E, Manola J, George DJ, Gilligan TD, Jacobson JO, Smith MR, Kaufman DS, Kantoff PW. Oh WK, et al. Among authors: kantoff pw. Clin Cancer Res. 2005 Jan 1;11(1):284-9. Clin Cancer Res. 2005. PMID: 15671557 Clinical Trial.

9

Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapy.

Ross RW, Manola J, Hennessy K, Galsky M, Scher H, Small E, Kelly WK, Kantoff PW. Ross RW, et al. Among authors: kantoff pw. Clin Cancer Res. 2005 Jul 15;11(14):5195-8. doi: 10.1158/1078-0432.CCR-05-0431. Clin Cancer Res. 2005. PMID: 16033836

10

Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer.

Febbo PG, Richie JP, George DJ, Loda M, Manola J, Shankar S, Barnes AS, Tempany C, Catalona W, Kantoff PW, Oh WK. Febbo PG, et al. Among authors: kantoff pw. Clin Cancer Res. 2005 Jul 15;11(14):5233-40. doi: 10.1158/1078-0432.CCR-05-0299. Clin Cancer Res. 2005. PMID: 16033841 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters